Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
41 Cards in this Set
- Front
- Back
What is the most common gynec cancer?
|
Endometrial
- 3/4 post-menopausal |
|
What are the two types?
|
Type I: Estrogen Dependent
Type II: Non estrogen dependent |
|
Screening: Endometrial
|
None.
|
|
Findings: Warning Signs
|
Metromenorrhagia
Post-menopausal bleeding Abdo / bowel symptoms Post-coital bleeding |
|
What is the best choice for diagnosis?
|
Pipelle biopsy. 90% sensitive.
NOT U/S. Role for U/S is in work-up for AUB. |
|
Role of surgery (hysterectomy - BSO)
|
Diagnosis
Staging Treatment Facilitate adjuvant therapy |
|
FIGO Staging
|
I: uterus
II: involves cervix III: involves pelvis and nodes IV: bladder / bowel or mets |
|
Prognosis
|
Type I: 90% 5YSR
Type II: 10% %YSR |
|
Cervical Cancer:
cause and co-factors |
Cause = HPV
Cofactors: smoking, immunocomprosise |
|
Types
- warts - cancer |
Warts: 6, 11
Cancer: 16, 18 |
|
Primary prevention:
Secondary: |
Primary: avoid getting HPV
Secondary: Pap, Colposcopy |
|
How sensitive is Pap?
|
50-90%
Repetition necessary! |
|
What are the types of irregular results in a pap?
|
Sqamous: ASC - US, ASC-H, LSIL, HSIL, Carcinoma
Glandular: AGC, AGC favour neoplasia, Adenocarcinoma |
|
What is the next step when irregular result returned?
|
Except for ASC-US, do COLPOSCOPY
ASC-US is the only indication for HPV testing. |
|
Tx: Dysplasia
|
Excision or Ablation
|
|
What are some cervical cancer warning symptoms?
|
POST - COITAL BLEEDING
Pain, d/c Terrible Triad: flank pain, sciatica, lower limb edema |
|
What do you do if you find a gross lesion on pelvic exam?
|
BIOPSY
|
|
How is cervical cancer staged?
|
Clinically. Imaging may help with Tx but does not determine staging.
|
|
FIGO Stages: Cervical Cancer
|
I: Cervix
II: upper vagina / parametrium III: lower vagina, pelvic sidewall, ureters IV: bladder / bowel / mets |
|
Tx Cervical Cancer
|
> 1B2: Chemoradiation; no surgery
< 1B2: radical hysterectomy + nodes |
|
Prognosis: Cervical Cancer
|
Early stage: 2/3 5ysr
Later stage: 1/3 5 ysr |
|
Ovarian Tumours: Types
|
Germ (good-- chemosensitive)
Stromal (bad) Epithelial (ugly) |
|
Risk factors
|
Excessive ovulation
- nulliparity - early menarche / late menopause - OCPs protective |
|
Hereditary Syndromes
|
- Breast / Ovarian: BRCA 1/ 2
- Lynch (HNPCC) - Earlier onset, better outcome |
|
Screening
|
NONE. Ca-125 does not work.Do screening for those with BRCA or HNPCC.
|
|
Warning Signs: Ovarian Cancer
|
Bloating
Abdo / gut / bladder Irregular vaginal bleeding (uncommon) Ascites, frozen pelvis |
|
Dx
|
Pelvic or TVUS
CT no good P/E !!! |
|
Markers for Ovarian Tumours
|
Epithelial, non-mucinous: Ca-125
Germ cell: none for immature teratoma; others Stromal, granulosa type: Inhibin |
|
What is the use fo CA-125?
|
No use in premenopausal but high PPV in postmenopausal
|
|
What is the RMI?
|
Risk of Malignancy Index
RMI = U x M x CA > 200 = gyno referral U/ S (1 or 3 points) 1 for 0, 1 points; 3 for 2-5 points: multilocularity, bilaterality, solid components, ascites, mets M = 3 for menopausal, 1 for pre CA = serum Ca 125 |
|
FIGO Staging
|
I: ovaries
II: pelvis III: abdomen, pelvis, nodes IV: pleural effusion, liver, mets |
|
Tx: ovarian cancer
|
Surgery. Also helps with staging.
|
|
Prognosis
|
Most not diagnosed till later, so bad outcome.
|
|
Vulvar Cancer: most common subtype
|
squamous cell carcinoma
22% are actually secondaries. |
|
What are the two categories of vulvar cancer?
|
HPV related (Type I) - similar risk factors (smoking, IC etc) to cervical cancer
Non-HPV related (Type II), eg with lichen sclerosus Age = major risk factor (disease of older people) |
|
Warnings Signs
|
Itching, burning, bleeding, lesion
|
|
Investigation:
|
Colposcopy (if no lesion visible) and biopsy
Pap Smear-- No! |
|
Tx
|
Surgery with adjuvant and neoadjuvant chemoradiation
|
|
FIGO Staging
|
I: vulvar tumour < 2cm
II: vulvar tumour > 2cm III: urethra, anus, vagina, nodes IV: bladder / bowel, bones, mets |
|
Outcome
|
Very good at early stage. Only 18% at Stage IV.
|
|
STUDY SUMMARY SLIDES
|
STUDY SUMMARY SLIDES
|